These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 30022320

  • 1. The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.
    Kocyigit I, Eroglu E, Kaynar AS, Kocer D, Kargi S, Zararsiz G, Bayramov R, Imamoglu H, Sipahioglu MH, Tokgoz B, Dundar M, Oymak O.
    J Nephrol; 2019 Feb; 32(1):83-91. PubMed ID: 30022320
    [Abstract] [Full Text] [Related]

  • 2. Multiple urinary tract infections are associated with genotype and phenotype in adult polycystic kidney disease.
    Eroglu E, Kocyigit I, Cetin M, Zararsiz G, Imamoglu H, Bayramov R, Tastan S, Sipahioglu MH, Tokgoz B, Oymak O.
    Clin Exp Nephrol; 2019 Oct; 23(10):1188-1195. PubMed ID: 31165946
    [Abstract] [Full Text] [Related]

  • 3. Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease.
    Kocyigit I, Ozturk F, Eroglu E, Karaca Z, Kaynar AS, Cetin M, Tokgoz B, Sipahioglu MH, Bayramov R, Sen A, Oymak O, Ecder T, Axelsson J.
    Clin Exp Nephrol; 2019 Sep; 23(9):1130-1140. PubMed ID: 31134465
    [Abstract] [Full Text] [Related]

  • 4. [Genotype-phenotype correlation in ADPKD: a possible role for NGAL?].
    Virzì GM, Gastaldon F, Corradi V, de Cal M, Cruz DN, Clementi M, Ronco C.
    G Ital Nefrol; 2013 Sep; 30(4):. PubMed ID: 24941494
    [Abstract] [Full Text] [Related]

  • 5. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
    Cornec-Le Gall E, Audrézet MP, Renaudineau E, Hourmant M, Charasse C, Michez E, Frouget T, Vigneau C, Dantal J, Siohan P, Longuet H, Gatault P, Ecotière L, Bridoux F, Mandart L, Hanrotel-Saliou C, Stanescu C, Depraetre P, Gie S, Massad M, Kersalé A, Séret G, Augusto JF, Saliou P, Maestri S, Chen JM, Harris PC, Férec C, Le Meur Y.
    Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum uromodulin levels, MR imaging findings, and their relationship with eGFR-based CKD staging in ADPKD patients.
    Cansever HN, Sari F, Cevikol C, Cetinkaya R, Süleymanlar G, Ersoy F.
    Int Urol Nephrol; 2021 Jul; 53(7):1383-1389. PubMed ID: 33389516
    [Abstract] [Full Text] [Related]

  • 8. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M, Inci A.
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [Abstract] [Full Text] [Related]

  • 9. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
    Kline TL, Korfiatis P, Edwards ME, Bae KT, Yu A, Chapman AB, Mrug M, Grantham JJ, Landsittel D, Bennett WM, King BF, Harris PC, Torres VE, Erickson BJ, CRISP Investigators.
    Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
    [Abstract] [Full Text] [Related]

  • 10. Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.
    Brosnahan GM, Abebe KZ, Moore CG, Rahbari-Oskoui FF, Bae KT, Grantham JJ, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Miskulin DC, Steinman TI, Torres VE, HALT-PKD Trial Investigators.
    Am J Kidney Dis; 2018 May; 71(5):666-676. PubMed ID: 29306517
    [Abstract] [Full Text] [Related]

  • 11. PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients.
    Ali H, Alahmad B, Senum SR, Warsame S, Bahbahani Y, Abu-Farha M, Abubaker J, Alqaddoumi M, Al-Mulla F, Harris PC.
    Am J Nephrol; 2024 May; 55(3):380-388. PubMed ID: 38194940
    [Abstract] [Full Text] [Related]

  • 12. The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.
    Cornec-Le Gall E, Audrézet MP, Rousseau A, Hourmant M, Renaudineau E, Charasse C, Morin MP, Moal MC, Dantal J, Wehbe B, Perrichot R, Frouget T, Vigneau C, Potier J, Jousset P, Guillodo MP, Siohan P, Terki N, Sawadogo T, Legrand D, Menoyo-Calonge V, Benarbia S, Besnier D, Longuet H, Férec C, Le Meur Y.
    J Am Soc Nephrol; 2016 Mar; 27(3):942-51. PubMed ID: 26150605
    [Abstract] [Full Text] [Related]

  • 13. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
    Raina R, Lou L, Berger B, Vogt B, Do AS, Cunningham R, Vasavada P, Herrmann K, Dell K, Simonson M.
    BMC Nephrol; 2016 Feb 29; 17():22. PubMed ID: 26923419
    [Abstract] [Full Text] [Related]

  • 14. The Clinical and Mutational Spectrum of 69 Turkish Children with Autosomal Recessive or Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study.
    Tutal O, Gulhan B, Atayar E, Yuksel S, Ozcakar ZB, Soylemezoglu O, Saygili S, Caliskan S, Inozu M, Baskin E, Duzova A, Hayran M, Topaloglu R, Ozaltin F.
    Nephron; 2024 Feb 29; 148(5):319-332. PubMed ID: 36657418
    [Abstract] [Full Text] [Related]

  • 15. Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.
    Lai S, Petramala L, Mastroluca D, Petraglia E, Di Gaeta A, Indino E, Panebianco V, Ciccariello M, Shahabadi HH, Galani A, Letizia C, D'Angelo AR.
    Medicine (Baltimore); 2016 Jul 29; 95(29):e4175. PubMed ID: 27442639
    [Abstract] [Full Text] [Related]

  • 16. Baseline characteristics of the autosomal-dominant polycystic kidney disease sub-cohort of the KoreaN cohort study for outcomes in patients with chronic kidney disease.
    Kim H, Koh J, Park SK, Oh KH, Kim YH, Kim Y, Ahn C, Oh YK.
    Nephrology (Carlton); 2019 Apr 29; 24(4):422-429. PubMed ID: 29797773
    [Abstract] [Full Text] [Related]

  • 17. Role of endothelin and nitric oxide in the pathogenesis of arterial hypertension in autosomal dominant polycystic kidney disease.
    Merta M, Reiterová J, Rysavá R, Tesar V, Závada J, Jáchymová M, Zima T.
    Physiol Res; 2003 Apr 29; 52(4):433-7. PubMed ID: 12899655
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL, Cadnapaphornchai MA, Chonchol MB, Schrier RW, Gitomer B.
    Am J Nephrol; 2016 Apr 29; 44(3):171-8. PubMed ID: 27548646
    [Abstract] [Full Text] [Related]

  • 19. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC, Kim J, Cho A, Kim DH, Lee YK, Ryu H, Kim H, Oh KH, Oh YK, Hwang YH, Lee KB, Kim SW, Kim YH, Lee J, Ahn C, KNOW-CKD Investigators Group.
    J Korean Med Sci; 2020 Jun 08; 35(22):e165. PubMed ID: 32508065
    [Abstract] [Full Text] [Related]

  • 20. Association of OSR-1 With Vascular Dysfunction and Hypertension in Polycystic Kidney Disease.
    Kocyigit I, Taheri S, Eroglu E, Zararsiz G, Sener EF, Uzun I, Imamoglu H, Mehmetbeyoglu E, Unal A, Korkmaz K, Sipahioglu MH, Oymak O, Tokgoz B.
    Ther Apher Dial; 2020 Feb 08; 24(1):64-71. PubMed ID: 31020807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.